Please use the link to the right for the complete profile.


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis. Van Kaer L, Wu L, Parekh VV (2015) Immunology 146(1): 1-10
    › Primary publication · 26032048 (PubMed) · PMC4552496 (PubMed Central)
  2. The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their Products. Van Kaer L, Parekh VV, Wu L (2015) Front Immunol : 226
    › Primary publication · 26029211 (PubMed) · PMC4429631 (PubMed Central)
  3. Spleen supports a pool of innate-like B cells in white adipose tissue that protects against obesity-associated insulin resistance. Wu L, Parekh VV, Hsiao J, Kitamura D, Van Kaer L (2014) Proc Natl Acad Sci U S A 111(43): E4638-47
    › Primary publication · 25313053 (PubMed) · PMC4217427 (PubMed Central)
  4. Contribution of lipid-reactive natural killer T cells to obesity-associated inflammation and insulin resistance. Wu L, Van Kaer L (2013) Adipocyte 2(1): 12-16
    › Primary publication · 23700548 (PubMed) · PMC3661135 (PubMed Central)
  5. Impaired autophagy, defective T cell homeostasis, and a wasting syndrome in mice with a T cell-specific deletion of Vps34. Parekh VV, Wu L, Boyd KL, Williams JA, Gaddy JA, Olivares-Villagómez D, Cover TL, Zong WX, Zhang J, Van Kaer L (2013) J Immunol 190(10): 5086-101
    › Primary publication · 23596309 (PubMed) · PMC3646937 (PubMed Central)
  6. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells. Parekh VV, Wu L, Olivares-Villagómez D, Wilson KT, Van Kaer L (2013) J Immunol 190(5): 1948-60
    › Primary publication · 23345328 (PubMed) · PMC3577977 (PubMed Central)
  7. Invariant natural killer T cells as sensors and managers of inflammation. Van Kaer L, Parekh VV, Wu L (2013) Trends Immunol 34(2): 50-8
    › Primary publication · 23017731 (PubMed) · PMC3615427 (PubMed Central)
  8. Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. Wu L, Parekh VV, Gabriel CL, Bracy DP, Marks-Shulman PA, Tamboli RA, Kim S, Mendez-Fernandez YV, Besra GS, Lomenick JP, Williams B, Wasserman DH, Van Kaer L (2012) Proc Natl Acad Sci U S A 109(19): E1143-52
    › Primary publication · 22493234 (PubMed) · PMC3358828 (PubMed Central)
  9. Natural killer T cells in health and disease. Wu L, Van Kaer L (2011) Front Biosci (Schol Ed) 3(1): 236-51
    › Primary publication · 21196373 (PubMed) · PMC3626278 (PubMed Central)
  10. Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens. Van Kaer L, Parekh VV, Wu L (2011) Immunotherapy 3(1): 59-75
    › Primary publication · 21174558 (PubMed)
  11. Invariant natural killer T cells: bridging innate and adaptive immunity. Van Kaer L, Parekh VV, Wu L (2011) Cell Tissue Res 343(1): 43-55
    › Primary publication · 20734065 (PubMed) · PMC3616393 (PubMed Central)